NASDAQ:IBB iShares Biotechnology ETF (IBB) Price, Holdings, & News $122.22 -0.63 (-0.51%) As of 03:02 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrendsBuy This Stock About iShares Biotechnology ETF (NASDAQ:IBB) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IBB alerts:Sign Up Key Stats Today's Range$121.90▼$123.2550-Day Range$112.02▼$135.3152-Week Range$107.43▼$150.57Volume976,038 shsAverage Volume1.59 million shsMarket Capitalization$5.35 billionAssets Under Management$5.23 billionDividend Yield0.31%Net Expense Ratio0.45%Aggregate RatingModerate Buy ETF OverviewiShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.Read More… iShares Biotechnology ETF ExpensesTypeIBBHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.45%0.57%0.57%0.54%0.53%Other Expenses0.00%0.30%0.48%0.42%0.51%Total Expense0.45%0.70%0.72%0.68%0.71%Fee Waiver0.00%-0.45%-0.49%-0.29%-0.54%Net Expense0.45%0.61%0.63%0.62%0.60% Receive IBB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address IBB ETF News HeadlinesTrump is right about drug prices. He's just going about it all wrong.May 13, 2025 | marketwatch.comHealth Care Stocks (IBB) Live: President Trump Promises Lower Drug Prices, Stocks MovingMay 12, 2025 | msn.comAs Bitcoin supply vanishes, this Trump-aligned token could explodeBitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, the REAL opportunity lies with one specific altcoin that's perfectly positioned to capture the lion's share of capital… May 28, 2025 | Crypto 101 Media (Ad)Nasdaq iShares Biotechnology ETF – IBB Elliott Wave technical analysis [Video]May 9, 2025 | fxstreet.comNasdaq iShares Biotechnology ETF (IBB) Elliott Wave analysis [Video]April 28, 2025 | fxstreet.comHealthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'April 9, 2025 | cnbc.comSee More Headlines IBB ETF - Frequently Asked Questions How have IBB shares performed this year? iShares Biotechnology ETF's stock was trading at $132.21 on January 1st, 2025. Since then, IBB shares have decreased by 7.7% and is now trading at $122.0390. View the best growth stocks for 2025 here. When did iShares Biotechnology ETF's stock split? iShares Biotechnology ETF shares split on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly issued shares were payable to shareholders after the market closes on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split. Who are iShares Biotechnology ETF's major shareholders? iShares Biotechnology ETF's top institutional investors include Citigroup Inc. (7.33%), BNP Paribas Financial Markets (2.09%), Royal Bank of Canada (1.75%) and Commerce Bank (1.37%). How do I buy shares of iShares Biotechnology ETF? Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of iShares Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Biotechnology ETF investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and iShares Micro-Cap ETF (IWC). Fund Details IssueriShares Fund NameiShares Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:IBB Inception Date2/5/2001 Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNYSE Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings263 Fund Statistics Assets Under Management$5.19 billion Average Daily Volume$2.00 million Discount/Premium-0.12% Administrator, Advisor and Custodian AdministratorJ.P. Morgan Chase Bank, N.A. AdvisorBlackRock Fund Advisors CustodianJPMorgan Chase Bank, N.A. DistributorBlackRock Investments, LLC Transfer AgentJ.P. Morgan Chase Bank, N.A. TrusteeN/A Lead Market MakerLatour Trading Options OptionableOptionable Options Volume3,214 Put Options2,691 Call Options523 Short Interest11,120,000 shs Miscellaneous Outstanding Shares43,750,000Beta0.84 Creation Unit50,000 Creation Fee$614.00 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report Top 10 IBB HoldingsVertex Pharmaceuticals (NASDAQ:VRTX)Holding Weight: 8.42%Amgen (NASDAQ:AMGN)Holding Weight: 8.20%Gilead Sciences (NASDAQ:GILD)Holding Weight: 8.16%Regeneron Pharmaceuticals (NASDAQ:REGN)Holding Weight: 7.46%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 4.24%IQVIA (NYSE:IQV)Holding Weight: 2.96%argenx (NASDAQ:ARGX)Holding Weight: 2.86%Mettler-Toledo International (NYSE:MTD)Holding Weight: 2.85%Waters (NYSE:WAT)Holding Weight: 2.52%Natera (NASDAQ:NTRA)Holding Weight: 2.31%Full Holdings DetailsIBB Sector ExposureIBB Industry Exposure This page (NASDAQ:IBB) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.